VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 71335-1509
- 11-digit product format
- 713351509
- Labeler code
- 71335
- Product ID
- 71335-1509_86f011de-c58d-4e6a-a9d2-3d331906dbf3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090899
- Marketing category
- ANDA
- Marketing start
- 2011-01-06
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1509-1 | 71335150901 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1509-1) | 2022-03-16 | 0000-00-00 | No | No | Current |
| 71335-1509-2 | 71335150902 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1509-2) | 2022-03-16 | 0000-00-00 | No | No | Current |
| 71335-1509-3 | 71335150903 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1509-3) | 2022-03-16 | 0000-00-00 | No | No | Current |
| 71335-1509-4 | 71335150904 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1509-4) | 2022-03-16 | 0000-00-00 | No | No | Current |